Navigation Links
Health Media Network Broadcasts 'The Wumblers'
Date:9/9/2008

Popular Children's Television Series Debuts on Health Media Network on

October 1, 2008

NEW YORK, Sept. 9 /PRNewswire/ -- Health Media Network announced the addition of the popular children's program "The Wumblers" to its schedule of digital television broadcasts starting October 1, 2008. With its strong emphasis on multicultural programming, Health Media Network is a perfect home for the cartoon series, whose audience spans a diverse cross section of the population.

"The Wumblers" is both a TV series and brand that has been strongly embraced by the U.S. Hispanic-Latino population. The Wumblers are a whimsical collection of multi-colored, bulbous-shaped characters whose stories blend inspiration, imagination, and fun. The program is produced by The Giddy Gander Company.

"As The Wumblers' primary focus is to support children and families, doing so in medical-related environments is an obvious choice," states Laura J. Wellington, CEO, of The Giddy Gander Company and creator of "The Wumblers". "We are quite pleased to team with Health Media Network in this regard."

The series will be broadcast over Health Media Network (HMN). HMN programming is broadcasted in waiting rooms and treatment areas of major metropolitan hospitals and medical practices. Health Media Network's digital television screens and poster displays reach millions of health-minded consumers, patients, and medical employees every month. Health Media Network's digital television system (HMN TV) consists of 42" LCD widescreen monitors with individual IP addresses so both content and advertising can be sent to specific locations within our network on behalf of marketers.

HMN is a strong multicultural channel -- generating over 68 million Hispanic impressions annually according to Arbitron. "The Wumblers" will be broadcast over HMN's Parenting Network and Women's Wellness Network. The program will be broadcast in English and Spanish. '/>"/>

SOURCE Health Media Network
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Health Insurance Industry Hosts Roundtable Discussion on Health Care Reform in Albuquerque
2. Quotebroker Expands Territory by Offering Affordable Health Insurance Quotes to Arizona Residents
3. Universal Health Services, Inc. Announces Sale of Acute Care Hospital and Addition of Two Behavioral Health Hospitals
4. UNC receives record $181 million grant to evaluate health, poverty and gender programs worldwide
5. Healthcare Executive Richard Peitzmeier Returns to Phoenix as Regional Sales Director of SCAN Health Plan Arizona
6. National Health Plan Collaborative Launches Online Toolkit to Assist Health Plans in Reducing Disparities
7. Association for the Advancement of Wound Care Leads World Health Organization Initiative to Establish Guidelines for Wound and Lymphedema Care
8. Healthy individuals may be at risk for heart disease
9. HRSA Announces $39 Million in Grants to Expand, Improve Health Center Services
10. Conventions Conclude, Fall Campaign Begins: NFIB Looks for More Focus on Small Business Healthcare Concerns
11. ULURU Inc. to Present at the Thomas Weisel Partners Healthcare Conference 2008

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/27/2009)..., Nov. 27 Preventing di...d fortunately every year, new vaccines are being a...accines boost immunity for the same period of time... needed to keep immunity strong? ,, In this m...rican Academy of Pediatrics, Michael Pichichero MD...
(Date:11/27/2009)...ecedented medical, economic burdens, study predict...- The number of people with diabetes in the United...rs, a new study predicts. , That would bring th...the disease, up from 23.7 million today. , , At ...abetes will triple, the study also warns, rising f...
(Date:11/27/2009)...hree new interactive anatomy education apps from M...nd health sciences learning opportunities for iPho...m, NC (Vocus) November 27, 2009 -- Modality, Inc....ivision of Wolters Kluwer Health, today announced ...ps on the App Store. Clemente’s Anatomy, Roh...
(Date:11/26/2009)...oo heavy can lead to strains or worse , ,...be nothing wrong with stuffing your turkey full to...hing with your suitcase as you pack for holiday tr...2008 in U.S. hospital emergency rooms, doctors, of...ggage-related injuries, such as muscle strains, pu...
(Date:11/26/2009)...enton Communications announces a highly effective ...ilers struggling to make an economic recovery. , ...-- Flu fears is the type of challenge that could s...cording to Dr. David Benton, business growth exper... system – The Rfactor Intensive . “...
Breaking Medicine News(10 mins):Health News:Why Some Vaccines May Require A Booster 2Health News:Why Some Vaccines May Require A Booster 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 2Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 3Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 4Health News:Clemente's Anatomy, Rohen's Photographic Anatomy, and Moore's Clinical Anatomy Customizable Apps Now Available on App Store 5Health News:Pack Right for the Holidays to Avoid the ER 2Health News:Pharmacist Injects Cure for Ailing Businesses 2
...gate Endpoints of Long-Term Survival in Prostate C...ant metastases 3 years after the start of treatmen...l in patients with early prostate cancer. , Prost...cause patients must be followed for many years. If...
...ity improved 22 percent as a result of My Health p...ated Benefits Institute (IBI) and the National Bus...e Mutual Insurance Company with the 2009 IBI/NBCH ... Reuters, recognizes leadership in the area of hea...
...r to have an effect on whether a patient with term...to a study led by researchers at Beth Israel Deaco...ary 2009 issue of the Journal of the American Ger...s and Hispanics. , According to senior author Ell...
...n Medicine announced today the results from an ong...6 at the 16th Conference on Retroviruses and Oppor... a gene therapy product being investigated for the... from their current antiretroviral therapy. , "W...
...l Insurance Company is one of 10 employers across ...Deserved Award. The award recognizes employers who...yees, health. , , UnitedHealthcare provides healt...ard applicants. Criteria included executive suppor...
...s just-released 2009 AEC Industry Outlook: Strate... reveals a shake-up in the markets that firm lead...ental consulting industries expect to be most prom...e ranked markets (higher education, K-12 schools, ...
Other Medicine News:Health News:Also in the Feb. 10 JNCI 2Health News:Also in the Feb. 10 JNCI 3Health News:Also in the Feb. 10 JNCI 4Health News:Also in the Feb. 10 JNCI 5Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 2Health News:Nationwide Receives IBI/NBCH Healthy Workforce Productivity Award 3Health News:Study finds race and ethnicity affect use of hospice services among patients with advanced cancer 2Health News:Penn Medicine presents HIV gene therapy trial data at CROI 2009 2Health News:Texas Mutual Wins National Employee Wellness Award 2Health News:New Study Reveals Shake-Up in the Most Promising AEC Markets for 2009 2
(Date:11/25/2009)...e/ -- Reportlinker.com announces that a new market..., Mammography Equipment - A Global Market Pers...330/Mammography-Equipment---A-Global-Market-Perspe...r in industrialized as well as developing nations ...mmography market. Globally, escalating awareness a...
(Date:11/25/2009)...Newswire/ -- Cempra Pharmaceuticals Inc. today ann...hief executive officer, will present at the Piper ... a.m. EST, December 1, 2009, at The New York Palac...ide an overview of the company,s two leading antib...resistant pathogens including MRSA. ,, About C...
(Date:11/25/2009)...ewswire/ -- ChemoCentryx, Inc., announced today ... PROTECT-1 (the Prospective Randomized Oral Therap...-EN(TM) (CCX282-B) in patients with moderate-to-se...y with a favorable safety and tolerability profile...icacy in the reduction of disease severity as defi...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 1FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 2FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 3FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 4FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 5FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 6FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 7FDA Advisory Committee Recommends Approval of PEGINTRON 28R 29 for the Adjuvant Treatment of Stage III Malignant Melanoma 58879 8PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 1PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 2PEAK Surgical and Medtronic Announce Global Distribution Agreement for the Ear Nose and Throat Market 5231 3Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 1Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 2Kimberly Clark Acquires Baylis Medical Companys Pain Management Business 5227 3
...ain cell that was long overlooked by researchers e...ain differs fundamentally from that of a mouse or ...findings as the cover story in the March 11 issue ...at the University of Rochester Medical Center fo...ought simply to support flashier brain cells known...
.../ -- Results from the Phase II portion of a Phas...nal drug relaxin for the treatment of acute heart ...day, March 29, at the American College of Cardiolo...do, Fla. , , John R. Teerlink, M.D., professor of... , Director of Heart Failure, San Francisco Vetera...
Other Medicine Technology:Astrocytes Help Separate Man From Mouse 2Astrocytes Help Separate Man From Mouse 3Astrocytes Help Separate Man From Mouse 4Astrocytes Help Separate Man From Mouse 5Results From Efficacy and Safety Study of Corthera's Relaxin in Acute Heart Failure to be Presented at Late-Breaking Clinical Trials Session at ACC 58th Annual Scientific Session 2
Kratz-Barraquer Eye Speculum
Lehner Temporal Speculum
Wiener Eye Speculum
McKinney Eye Speculum
Medicine Products: